J. Garber

Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.

S. Zolla-Pazner, W. El-Sadr, S. Friedman, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Biological Validation of Self‐Reported AIDS Risk Reduction among New York City Intravenous Drug Users

S. Friedman, D. Mildvan, D. C. Jarlais, 1988 .

Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users.

J. Garber, W. El-Sadr, S. Friedman, 1987, AIDS.

Human Peritoneal Macrophages From Ascitic Fluid Can be Infected by a Broad Range of HIV-1 Isolates

A. Branch, T. Schiano, Theresa L. Chang, 2010, Journal of acquired immune deficiency syndromes.

Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York.

S. Friedman, S. Yancovitz, T. Spira, 1984, The New England journal of medicine.

AIDS and self-organization among intravenous drug users.

D. C. Jarlais, J. L. Sotheran, D. Smith, 1987, The International journal of the addictions.

Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis.

C. Sautès-Fridman, J. Odin, Bin Hu, 2008, Journal of autoimmunity.

Human Peritoneal Macrophages From Ascitic Fluid Can be Infected by a Broad Range of HIV-1 Isolates

A. Branch, T. Schiano, Theresa L. Chang, 2010, Journal of acquired immune deficiency syndromes.

Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid.

A. Branch, C. Rice, T. Schiano, 2011, Journal of virological methods.

A stage model of HTLV-III LAV infection in intravenous drug users.

S. Zolla-Pazner, S. Friedman, R. Holzman, 1986, NIDA research monograph.